View Section: Price ratios
KeyMed Statements
21
KeyMed Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2022-06-30
%
100
100
2.537
2.5
97.463
97.5
164.01
164
51.048
51
201.75
201.8
-104.29
-104.3
106.82
106.8
—
0
2.524
2.5
—
0
5.454
5.5
0.02
267.34
2021-12-31
%
110.27
100
17.2
15.6
93.069
84.4
167.09
151.5
65.618
59.5
355.86
322.7
-262.79
-238.3
-10.729
-9.7
—
0
-262.2
-237.8
—
0
-258.81
-234.7
-5.104
50.702
2021-06-30
%
—
100
—
0
—
0
191.06
0
26.836
0
3 608.57
0
-3 608.57
0
5.89
0
—
0
-3 630.43
0
—
0
-3 628.5
0
-13.389
271
View Section: Balance Sheet